Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular Risk

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text

Vascular Disease, Cardiovascular Disease, Medicine +15

Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

Jan T. Kielstein, Burcu Impraim, S. Simmel et al. · Circulation · 2003 · 403 citations · Full text

Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox

Jung-Hee Lee, Hoon Ryu, Robert J. Ferrante et al. · Proceedings of the National Academy of Sciences · 2003 · 361 citations

Synthase Expression, Immunology, Molecular Biology +25

L-Arginine Therapy in Acute Myocardial Infarction

Steven P. Schulman, Lewis C. Becker, David A. Kass et al. · JAMA · 2006 · 348 citations

Decreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma

Claudia R. Morris, Mirjana Poljakovic, Lisa Lavrisha et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 280 citations

Asthma, Inflammation, Allergy +13